Acute myeloid leukaemia

• Myechild 01: International Randomised Phase III Clinical Trial in Children with Acute Myeloid Leukaemia - Incorporating an Embedded Dose Fin … Recruitment ended
  2024-516112-21-00 5 2017-11-20 "Newly diagnosed acute myeloid leukaemia (AML), high risk mye"
• A research study looking at a new treatment for patients with advanced cancer, to investigate different doses of the experimental study drug … Halted
  2024-514588-24-00 7 2021-09-27 "Acute Myeloid Leukaemia (AML)"
• Phase 1 trial of LAVA-1266, a CD123-targeting bispecific Vγ9Vδ2-T cell engager, in patients with CD123 positive relapsed/refractory (R/R) ac … Ended
  2024-518831-12-00 1 2025-04-15 "CD123 positive R/R AML and intermediate risk, high risk, or "
• Safety, pharmacokinetics, and preliminary efficacy of BYON4413 in acute myeloid leukemia and myelodysplastic neoplasms. Ended
  2023-507781-13-00 1 2024-05-24 "Patients with relapsed/refractory acute myeloid leukemia or "
• A Multicenter, Open-Label Clinical Trial of RVU120 in Patients with Relapsed or Refractory High-Risk Myelodysplastic Syndrome or Acute Myelo … Ended
  2023-505910-10-00 4 2024-01-23 "Relapsed or Refractory High-Risk Myelodysplastic Syndrome"
• APTIVATE Clinical Trial to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Tuspetinib (HM43239) in Patients with … Ended
  2023-503244-14-00 7 2023-08-11 "Relapsed or Refractory Acute Myeloid Leukemia (AML)"
• LAMSA2020: “A phase II randomized study to assess the efficacy on outcome of Venetoclax combined with Cytarabine versus Idarubicin combined … Ended
  2022-502392-37-00 4 2022-05-25 "elderly patients (> = 60 years) with Acute Myeloid Leukemia"
• Tamibarotene/Venetoclax/Azacitidine in Previously Untreated Patients Selected for RARA-positive AML (SELECT-AML-1) Ended
  2024-510939-21-00 4 2022-04-01 "RARA-positive acute myeloid leukemia"
• A study to assess the effect of CC-95251 alone and in combination with anti-cancer drugs in subjects with Acute Myeloid Leukemia and Myelody … Ended
  2023-506117-22-00 3 2022-01-05 "Acute Myeloid Leukemia and Myelodysplastic Syndromes"
• A Dose Finding Phase 1 Study of CC-96191 in Subjects with Relapsed or Refractory Acute Myeloid Leukemia Ended
  2022-500573-13-00 1 2021-07-06 "Relapsed or Refractory Acute Myeloid Leukemia"
• VEN-DEC GITMO Study Ended
  2024-518792-54-00 4 2021-05-13 "Acute Myeloid Leukemia (AML)"
• Open Label 2-Arm Study of Venetoclax in Combination with Azacitidine Versus Best Supportive Care after Allogeneic Stem Cell Transplantation … Ended
  2023-507222-17-00 5 2020-07-24 "Acute Myeloid Leukaemia"
• A Biomarker-Directed Phase 2 Trial of SY-1425, a Selective Retinoic Acid Receptor Alpha Agonist, in Adult Patients with Acute Myeloid Leukem … Ended
  2024-516281-11-00 4 2018-06-06 "Acute Myeloid Leukemia (AML) Myelodysplastic Syndrome (MDS)"

Showing 25–37 of 37 trials